{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:13:49Z","timestamp":1787840029453,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12264-019-00421-5","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T01:02:27Z","timestamp":1566262947000},"page":"1024-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington\u2019s Disease"],"prefix":"10.1007","volume":"35","author":[{"given":"Weiqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexige","family":"Saiyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"key":"421_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 1993, 72: 971\u2013983.","journal-title":"Cell"},{"key":"421_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/mds.27363","volume":"33","author":"K Kieburtz","year":"2018","unstructured":"Kieburtz K, Reilmann R, Olanow CW. Huntington\u2019s disease: current and future therapeutic prospects. Mov Disord 2018, 33: 1033\u20131041.","journal-title":"Mov Disord"},{"key":"421_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/cge.12574","volume":"89","author":"F Squitieri","year":"2016","unstructured":"Squitieri F, Griguoli A, Capelli G, Porcellini A, D\u2019Alessio B. Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clin Genet 2016, 89: 367\u2013370.","journal-title":"Clin Genet"},{"key":"421_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/1531-8257(199901)14:1<95::AID-MDS1016>3.0.CO;2-8","volume":"14","author":"ED Louis","year":"1999","unstructured":"Louis ED, Lee P, Quinn L, Marder K. Dystonia in Huntington\u2019s disease: prevalence and clinical characteristics. Mov Disord 1999, 14: 95\u2013101.","journal-title":"Mov Disord"},{"key":"421_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-2007-971176","volume":"27","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Semin Neurol 2007, 27: 143\u2013150.","journal-title":"Semin Neurol"},{"key":"421_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1017\/S109285290002201X","volume":"6","author":"JR Slaughter","year":"2001","unstructured":"Slaughter JR, Martens MP, Slaughter KA. Depression and Huntington\u2019s disease: prevalence, clinical manifestations, etiology, and treatment. CNS Spectr 2001, 6: 306\u2013326.","journal-title":"CNS Spectr"},{"key":"421_CR7","first-page":"RRN1184","volume":"2","author":"M Orth","year":"2010","unstructured":"Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, et al. Observing Huntington\u2019s disease: the European Huntington\u2019s disease network\u2019s REGISTRY. PLoS Curr 2010, 2: RRN1184.","journal-title":"PLoS Curr"},{"key":"421_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp.2010.208264","volume":"82","author":"EH Aylward","year":"2011","unstructured":"Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 2011, 82: 405\u2013410.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"421_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S. The biology of Huntingtin. Neuron 2016, 89: 910\u2013926.","journal-title":"Neuron"},{"key":"421_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12264-016-0093-y","volume":"33","author":"HL Li","year":"2017","unstructured":"Li HL, Zhang YB, Wu ZY. Development of research on Huntington disease in China. Neurosci Bull 2017, 33: 312\u2013316.","journal-title":"Neurosci Bull"},{"key":"421_CR11","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277: 1990\u20131993.","journal-title":"Science"},{"key":"421_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"JM Lee","year":"2012","unstructured":"Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 2012, 78: 690\u2013695.","journal-title":"Neurology"},{"key":"421_CR13","first-page":"129","volume":"22","author":"WY Zhang","year":"2006","unstructured":"Zhang WY, Gu ZL, Liang ZQ, Qin ZH. Mitochondrial dysfunction and Huntington disease. Neurosci Bull 2006, 22: 129\u2013136.","journal-title":"Neurosci Bull"},{"key":"421_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.25717","volume":"29","author":"ER Fisher","year":"2014","unstructured":"Fisher ER, Hayden MR. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. Mov Disord 2014, 29: 105\u2013114.","journal-title":"Mov Disord"},{"key":"421_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrm2918","volume":"11","author":"M Taipale","year":"2010","unstructured":"Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 2010, 11: 515\u2013528.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"421_CR16","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc1716","volume":"5","author":"L Whitesell","year":"2005","unstructured":"Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005, 5: 761\u2013772.","journal-title":"Nat Rev Cancer"},{"key":"421_CR17","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1074\/jbc.M111.294801","volume":"287","author":"B Baldo","year":"2012","unstructured":"Baldo B, Weiss A, Parker CN, Bibel M, Paganetti P, Kaupmann K. A Screen for enhancers of clearance identifies Huntingtin as a heat shock protein 90 (Hsp90) client protein. J Biol Chem 2012, 287: 1406\u20131414.","journal-title":"J Biol Chem"},{"key":"421_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1326-5-24","volume":"5","author":"WJ Luo","year":"2010","unstructured":"Luo WJ, Sun WL, Taldone T, Rodina A, Chiosis G. Heat shock protein 90 in neurodegenerative diseases. Mol Neurodegener 2010, 5: 24.","journal-title":"Mol Neurodegener"},{"key":"421_CR19","doi-asserted-by":"publisher","first-page":"14797","DOI":"10.1038\/s41598-017-13711-7","volume":"7","author":"WT He","year":"2017","unstructured":"He WT, Xue W, Gao YG, Hong JY, Yue HW, Jiang LL, et al. HSP90 recognizes the N-terminus of Huntingtin involved in regulation of Huntingtin aggregation by USP19. Sci Rep 2017, 7: 14797.","journal-title":"Sci Rep"},{"key":"421_CR20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/hmg\/ddn419","volume":"18","author":"K Tokui","year":"2009","unstructured":"Tokui K, Adachi H, Waza M, Katsuno M, Minamiyama M, Doi H, et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum Mol Genet 2009, 18: 898\u2013910.","journal-title":"Hum Mol Genet"},{"key":"421_CR21","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1074\/jbc.M112.427328","volume":"288","author":"CA Patwardhan","year":"2013","unstructured":"Patwardhan CA, Fauq A, Peterson LB, Miller C, Blagg BS, Chadli A. Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis. J Biol Chem 2013, 288: 7313\u20137325.","journal-title":"J Biol Chem"},{"key":"421_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","volume":"10","author":"L Ma","year":"2012","unstructured":"Ma L, Hu B, Liu Y, Vermilyea Scott\u00a0C, Liu H, Gao L, et al. Human embryonic stem cell-derived gaba neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 2012, 10: 455\u2013464.","journal-title":"Cell Stem Cell"},{"key":"421_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12864-017-3745-z","volume":"18","author":"M van Hagen","year":"2017","unstructured":"van Hagen M, Piebes DGE, de Leeuw WC, Vuist IM, van Roon-Mom WMC, Moerland PD, et al. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington\u2019s disease cell model. BMC Genomics 2017, 18: 373.","journal-title":"BMC Genomics"},{"key":"421_CR24","doi-asserted-by":"publisher","first-page":"21647","DOI":"10.1074\/jbc.M109.016923","volume":"284","author":"J Legleiter","year":"2009","unstructured":"Legleiter J, Lotz GP, Miller J, Ko J, Ng C, Williams GL, et al. Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant Huntingtin fragment. J Biol Chem 2009, 284: 21647\u201321658.","journal-title":"J Biol Chem"},{"key":"421_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ab.2010.11.044","volume":"410","author":"A Weiss","year":"2011","unstructured":"Weiss A, Grueninger S, Abramowski D, Giorgio FP, Lopatin MM, Rosas HD, et al. Microtiter plate quantification of mutant and wild-type Huntingtin normalized to cell count. Anal Biochem 2011, 410: 304\u2013306.","journal-title":"Anal Biochem"},{"key":"421_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature05291","volume":"443","author":"DC Rubinsztein","year":"2006","unstructured":"Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443: 780\u2013786.","journal-title":"Nature"},{"key":"421_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12264-015-1528-y","volume":"31","author":"RW Button","year":"2015","unstructured":"Button RW, Luo SQ, Rubinsztein DC. Autophagic activity in neuronal cell death. Neurosci Bull 2015, 31: 382\u2013394.","journal-title":"Neuroscience Bulletin"},{"key":"421_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","volume":"8","author":"DH Lee","year":"1998","unstructured":"Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998, 8: 397\u2013403.","journal-title":"Trends Cell Biol"},{"key":"421_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4161\/auto.2703","volume":"2","author":"JJ Shacka","year":"2006","unstructured":"Shacka JJ, Klocke BJ, Roth KA. Autophagy, bafilomycin and cell death: the \u201ca-B-cs\u201d of plecomacrolide-induced neuroprotection. Autophagy 2006, 2: 228\u2013230.","journal-title":"Autophagy"},{"key":"421_CR30","first-page":"103","volume":"277","author":"E Brooks","year":"2004","unstructured":"Brooks E, Arrasate M, Cheung K, Finkbeiner SM. Using antibodies to analyze polyglutamine stretches. Methods Mol Biol 2004, 277: 103\u2013128.","journal-title":"Methods Mol Biol"},{"key":"421_CR31","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, et al. Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci 1999, 19: 2522\u20132534.","journal-title":"J Neurosci"},{"issue":"48\u201357","key":"421_CR32","first-page":"e44","volume":"94","author":"F Gasset-Rosa","year":"2017","unstructured":"Gasset-Rosa F, Chillon-Marinas C, Goginashvili A, Atwal RS, Artates JW, Tabet R, et al. Polyglutamine-expanded Huntingtin exacerbates age-related disruption of nuclear integrity and nucleocytoplasmic transport. Neuron 2017, 94: 48\u201357e44.","journal-title":"Neuron"},{"key":"421_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/sj.gt.3302702","volume":"13","author":"E Rodriguez-Lebron","year":"2006","unstructured":"Rodriguez-Lebron E, Paulson HL. Allele-specific RNA interference for neurological disease. Gene Ther 2006, 13: 576\u2013581.","journal-title":"Gene Ther"},{"key":"421_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40035-017-0101-9","volume":"6","author":"S Aguiar","year":"2017","unstructured":"Aguiar S, van der Gaag B, Cortese FAB. RNAi mechanisms in Huntington\u2019s disease therapy: siRNA versus shRNA. Transl Neurodegener 2017, 6: 30.","journal-title":"Transl Neurodegener"},{"key":"421_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ Ihry","year":"2018","unstructured":"Ihry RJ, Worringer KA, Salick MR, Frias E, Ho D, Theriault K, et al. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med 2018, 24: 939\u2013946.","journal-title":"Nat Med"},{"key":"421_CR36","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang S, Chang R, Yang H, Zhao T, Hong Y, Kong HE, et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J Clin Invest 2017, 127: 2719\u20132724.","journal-title":"J Clin Invest"},{"key":"421_CR37","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med 2018, 24: 927.","journal-title":"Nat Med"},{"key":"421_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","volume":"4","author":"MW Becher","year":"1998","unstructured":"Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, et al. Intranuclear neuronal inclusions in Huntington\u2019s disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 1998, 4: 387\u2013397.","journal-title":"Neurobiol Dis"},{"key":"421_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, et al. Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 1995, 269: 407\u2013410.","journal-title":"Science"},{"key":"421_CR40","doi-asserted-by":"publisher","first-page":"e112413","DOI":"10.1371\/journal.pone.0112413","volume":"9","author":"A Flierl","year":"2014","unstructured":"Flierl A, Oliveira LM, Falomir-Lockhart LJ, Mak SK, Hesley J, Soldner F, et al. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication. PLoS One 2014, 9: e112413.","journal-title":"PLoS One"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00421-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-019-00421-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00421-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T20:52:58Z","timestamp":1597783978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-019-00421-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1007\/s12264-019-00421-5","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors claim that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}